Navigation Links
Team to study health effects of botanical estrogens

CHAMPAIGN, Ill. An ongoing research initiative into the health effects of botanical estrogens will get an $8 million boost from the National Institutes of Health.

The Botanical Research Center, based at the University of Illinois, will address the many unknowns associated with use of botanical estrogens. These plants and plant-based compounds are often marketed as aids to prevent cancer, promote healthy aging or relieve menopausal symptoms. Researchers from Illinois, the University of Mississippi, Oregon State University and the FDA's National Center for Toxicological Research will contribute to the five-year effort.

This is the second $8 million grant from the NIH to Illinois to conduct research into the health effects of botanical estrogens. The first five-year initiative focused on soy isoflavones, compounds found in soybean that previous studies indicated had potential as anti-cancer and cholesterol-lowering agents. That grant yielded studies that showed that the positive or negative health consequences of exposure to soy isoflavones depend on the timing of the exposure (whether it occurs in early, mid, or late life), tissue type (breast or brain, for example), and dose.

Many women take plant-based estrogens (also called phytoestrogens) that are advertised as natural and, they presume, safer alternatives to hormone-replacement therapy.

Foods, supplements and extracts made from soy, licorice root, wild yam and dong quai, for example, are believed to reduce the occurrence of hot flashes, improve sex drive, lower the incidence or prevent the recurrence of breast cancer, enhance mental function or treat other health problems.

Today, phytoestrogens are added to teas and energy drinks, used as food additives and marketed as nutritional supplements. The estrogenic components of the plants such as the isoflavone genistein in soy are often extracted and used in highly concentrated form.

Research into their efficacy and safety has yielded mixed results. Consumption of some plants or extracts appears to reduce the risk of some cancers or minimize some of the unpleasant symptoms associated with menopause, while others have no effect. Still other studies, some of them conducted at Illinois, have found that certain phytoestrogens may actually induce cognitive problems, increase the recurrence of breast cancer and interfere with breast cancer treatment.

"The types of botanical estrogens that are being marketed are getting more and more potent," said William Helferich, a professor of food science and human nutrition at Illinois and the director of the new center. "We want to see if they really are effective or detrimental."

The new grant supports three projects led by Illinois faculty. The projects will explore whether and how phytoestrogens from soy, licorice root, dong quai and wild yam affect various tissues, influence gene expression or other cellular processes, increase or decrease the growth and metastasis of breast cancer tumors, influence bone loss or alter the rate of cognitive decline in aging. Two core areas will provide support to the three projects by authenticating and standardizing the botanical samples used in the studies and analyzing how the various compounds are utilized in the body.

Benita Katzenellenbogen, a professor of molecular and integrative physiology and of cell and developmental biology at Illinois, will lead a project to study the effects of botanical estrogens on gene activation and their interaction with estrogen receptors and regulatory proteins.

Helferich will lead a project to investigate the effects of botanical estrogens on bone, uterus and mammary glands, and their effects on the growth and progression of breast cancer and its metastasis to bone, lung or other tissues.

Illinois comparative biosciences professor Susan Schantz will serve as the associate director of the center and together with Illinois psychology professor Donna Korol and Oregon State University professors Russ Turner and Urszula T. Iwaniec will lead a project to study the effects of botanical estrogens on cognitive function and bone health.

Ikhlas Khan, of the University of Mississippi, will authenticate and standardize botanical samples used in the research.

Daniel Doerge, of the FDA's National Center for Toxicological Research, will identify and quantify the samples used in the study and determine appropriate dosing.


Contact: Diana Yates
University of Illinois at Urbana-Champaign

Related medicine news :

1. Institute for Aging Research study finds indoor and outdoor fall are different for the elderly
2. Study finds more Americans bypassing their personal physician when immediate treatment required
3. Autistic Toddlers Prefer to Gaze at Geometric Patterns: Study
4. Many hospital emergency department visits could be treated elsewhere, study finds
5. Study examines association between urban living and psychotic disorders
6. Mouse Study May Help Explain Fish Oils Benefits
7. Infants May Display Subtle Autism Signs at 6 Months: Study
8. Queens study exposes cognitive effects of Parkinsons disease
9. Study challenges value of oxygen therapy in end-of-life care
10. Study finds that cancer-causing gene crucial in stem cell development
11. Safety cultures in EMS agencies vary widely, Pitt study finds
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think ... customers choose to buy during the Black Friday and Cyber Monday massage chair ... to search the Internet high and low to find the best massage chair deals, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced ... franchise owner, Somu now offers travelers, value and care based Travel Services, including ... sales, as well as, cabin upgrades and special amenities such as, shore excursions, ...
(Date:11/26/2015)... ... 2015 , ... Jobs in hospital medical laboratories and in the imaging field ... agency Aureus Medical Group . These fields, as well as travel ... for healthcare jobs through the company’s website, , The leading healthcare ...
(Date:11/26/2015)... BOSTON, Mass. (PRWEB) , ... November 26, 2015 ... ... a thorough second medical opinion process, participated in the 61st annual Employee Benefits ... Benefit Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... health and wellness consultation, has collaborated with Women’s Web – an online ... queries on topics on mental and emotional well-being relationship, life balance, stress, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/27/2015)... 27, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), ... biopharmaceuticals company UCB S.A. (Euronext: UCB). ... acquired KU from UCB for total consideration of ... a customary working capital adjustment, a deduction of ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: